Kynam Capital Management, LP Q4 2021 Filing
Filed February 14, 2022
Portfolio Value
$187.1B
Holdings
31
Report Date
Q4 2021
Filing Type
13F-HR
All Holdings (31 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 1,092,949 | $29.1B | 15.54% | Call |
| 2 | XENEXENON PHARMACEUTICALS INC | 670,093 | $20.9B | 11.19% | |
| 3 | SNDXSYNDAX PHARMACEUTICALS INC | 956,165 | $20.9B | 11.19% | |
| 4 | GOSSGOSSAMER BIO INC | 1,016,857 | $11.5B | 6.15% | |
| 5 | BIIBBIOGEN INC | 40,000 | $9.6B | 5.13% | |
| 6 | TCE2CELLDEX THERAPEUTICS INC NEW | 226,726 | $8.8B | 4.68% | |
| 7 | AMRNAMARIN CORP PLC | 2,210,866 | $7.5B | 3.98% | |
| 8 | VERAVERA THERAPEUTICS INC | 253,449 | $6.8B | 3.62% | |
| 9 | LQDALIQUIDIA CORPORATION | 1,366,836 | $6.7B | 3.56% | |
| 10 | AM6AMICUS THERAPEUTICS INC | 573,699 | $6.6B | 3.54% | |
| 11 | VRDNVIRIDIAN THERAPEUTICS INC | 287,934 | $5.7B | 3.04% | |
| 12 | TVTXTRAVERE THERAPEUTICS INC | 182,103 | $5.7B | 3.02% | |
| 13 | FATEFATE THERAPEUTICS INC | 95,561 | $5.6B | 2.99% | |
| 14 | PCVXVAXCYTE INC | 211,483 | $5.0B | 2.69% | |
| 15 | WVEWAVE LIFE SCIENCES LTD | 1,494,594 | $4.7B | 2.51% | |
| 16 | MRUSMERUS N V | 122,158 | $3.9B | 2.08% | |
| 17 | BNRBURNING ROCK BIOTECH LTD | 382,464 | $3.6B | 1.95% | |
| 18 | —ZOGENIX INC | 205,800 | $3.3B | 1.79% | |
| 19 | OLMAOLEMA PHARMACEUTICALS INC | 293,799 | $2.8B | 1.47% | |
| 20 | CNTACENTESSA PHARMACEUTICALS PLC | 239,041 | $2.7B | 1.44% | |
| 21 | MCRB1EURSERES THERAPEUTICS INC | 304,901 | $2.5B | 1.36% | |
| 22 | CABACABALETTA BIO INC | 644,583 | $2.4B | 1.31% | |
| 23 | KRYSKRYSTAL BIOTECH INC | 34,816 | $2.4B | 1.30% | |
| 24 | PBYIPUMA BIOTECHNOLOGY INC | 683,619 | $2.1B | 1.11% | |
| 25 | —AFFIMED N V | 364,033 | $2.0B | 1.07% | |
| 26 | —RADIUS HEALTH INC | 194,082 | $1.3B | 0.72% | |
| 27 | COGTCOGENT BIOSCIENCES INC | 150,000 | $1.3B | 0.69% | |
| 28 | —AKOUOS INC | 99,008 | $842.0M | 0.45% | |
| 29 | —NEOLEUKIN THERAPEUTICS INC | 147,000 | $709.0M | 0.38% | |
| 30 | GYRECATALYST BIOSCIENCES INC | 110,991 | $101.0M | 0.05% | |
| 31 | ALLKGUSDALLAKOS INC | 74,500 | $2.0M | 0.00% | Call |